StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Norethisteronacetat

Norethisterone Acetate

HCID 5832
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
51-98-9
Standard-SMILES
C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C
InChIKey
IMONTRJLAWHYGT-ZCPXKWAGSA-N
Summenformel
C22H28O3
Durchschnittliche Molmasse
340,5 g/mol
Monoisotopische Masse
340,20384475

Überblick

Norethisterone Acetate (Norethindrone Acetate) can cause developmental toxicity according to state or federal government labeling requirements.

Namen und Bezeichner

Bevorzugter Name
Norethisterone Acetate
IUPAC
[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
Lokaler Name
Norethisteronacetat
Englischer Name
19-Norethindrone acetate
Summenformel
C22H28O3
Molmasse
340.46

Namen und Synonyme

Norethindrone acetateNorethisterone acetate51-98-919-Norethindrone acetateNorlutin acetateENTANorethisteron acetate19-Norethisterone acetateNorethindrone 17-acetate19-Norethynyltestosterone acetate(17-alpha)-Norethindrone acetateNorethynyltestosterone
Weitere Namen anzeigen
Aygestinsh42017-EntSH 420SH-420COrlutateprogylut
17alpha-Ethynyl-19-nortestosterone acetateDTXSID4023381Norethisterone 17-acetate17-alpha-Ethinyl-19-nortestosterone acetate17-alpha-Ethynyl-19-nortestosterone acetate9S44LIC7OJNorethindrone acetate [USP]NSC-22844

Datenbank-Bezeichner

CAS
51-98-9
PubChem CID
5832
DTXSID
DTXSID4023381

Eigenschaften

Berechnete Struktureigenschaften

XLogP
3,5
Polarare Oberfläche (TPSA)
43,4 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
3
Schwere Atome
25
Formalladung
0
Komplexität
695

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section186.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
161 · 161-162°
Siedepunkt
416.25 °C · 416.25°C (rough estimate)
Dichte
1.1236 · 1.1236 (rough estimate)
Brechungsindex
-34 ° · -34 ° (C=1, Dioxane)
storage temp.
2 · 2-8°C
Löslichkeit
Practically insoluble in water, freely soluble in methylene chloride, soluble in alcohol.
Aggregatzustand
Solid
Farbe
2 CO/hexane · Crystals from Me2CO/hexane

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H302 (16.5%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P263, P264, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 115 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationHazard Traits - Developmental Toxicity
Other Safety InformationIMAP assessments - 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17.alpha.)-: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (16.5%)

Toxikologische Informationen

Treatment · 1 Eintrag

The treatment of choice for S. aureus infection is penicillin, but in most countries, penicillin-resistance is extremely common and first-line therapy is most commonly a penicillinase-resistant penicillin (for example, oxacillin or flucloxacillin). Combination therapy with gentamicin may be used to treat serious infections like endocarditis, but its use is controversial because of the high risk of damage to the kidneys. The duration of treatment depends on the site of infection and on severity. (L1773)

Health EffectsEnterotoxins are cytotoxic. (L1780)
Exposure Routes

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Free toxin may be removed by opsonization via the reticuloendothelial system (primarily the liver and kidneys) or it may be degraded through cellular internalization via the lysosomes. Lysosomes are membrane-enclosed organelles that contain an array of digestive enzymes, including several proteases.

FDA Pharmacological Classification · 2 Einträge

NORETHINDRONE ACETATE

Progestin [EPC]; Progesterone Congeners [CS]

MeSH Pharmacological Classification · 2 Einträge

Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.

Contraceptive agents that act on the ENDOCRINE SYSTEM.

Verwendung und Herstellung

UsesEnterotoxin type A is one of many enterotoxins produced by Staphylococcus aureus. (L1780)
Use ClassificationPharmaceuticals

Anwendungen

VerwendenProgesteron. Norethindrone and acetate in combination with estrogen as contraceptive (oral). It is reasonably anticipated to be a human carcinogen.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

HydrogenchloridEssigsäureanhydridNorethisteron

Zugehörige Reaktionen

4
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 859808
HRID 859808als Eduktuspto-grants-2006_12
Reaktionsgleichung von HRID 973095
HRID 973095als Eduktuspto-grants-1977_10
Reaktionsgleichung von HRID 988926
HRID 988926als Eduktuspto-grants-2003_10
Reaktionsgleichung von HRID 1578255
HRID 1578255als Eduktuspto-grants-1981_09

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
ChEMBL
CHEMBL1201146
ChEBI
CHEBI:7628
UNII
9S44LIC7OJ
EC Number
200-132-0
Nikkaji
J1.910K
Wasserlöslichkeit
3.162 mg/L · 3.162mg/L(10 ºC)
Merck
14 · 14,6697
Major Application
pharmaceutical small molecule
InChI
InChI=1/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22-/s3
InChIKey
IMONTRJLAWHYGT-ZCPXKWAGSA-N
SMILES
C[C@]12CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]3([H])[C@]1([H])CC[C@]2(C#C)OC(=O)C |&1:1,4,6,16,18,22,r|
CAS Datenbank
51 · 51-98-9(CAS DataBase Reference)
NIST chemische Informationen
Norethindrone acetate(51-98-9)
Ingestion (L1816) ; inhalation (L1816) ; dermal (L1816)
Toxicity Summary · 1 Eintrag

The action of enterotoxins leads to increased chloride ion permeability of the apical membrane of intestinal mucosal cells. These membrane pores are activated by either increased cAMP or by increased calcium ion concentration intracellularly. The pore formation has a direct effect on the osmolarity of the luminal contents of the intestines. Increased chloride permeability leads to leakage into the lumen followed by sodium and water movement. This leads to a secretory diarrhea within a few hours of ingesting enterotoxin. (L1780)

Signs and SymptomsEnterotoxins cause diarrhea. (L1780)
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Norethindrone acetate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
3
hs_code
29372390
RTECS-Nr.
RC8965000
risk_code
40-48
Toxizität
dlt-mus-orl 1120 mg/kg/4W MUREAV 26,535,74
hazard_code
Xn
safety_code
36/37
Speicherklasse
6.1D - Non-combustible acute toxic Cat.3toxic hazardous materials or hazardous materials causing chronic effects
Hazard Classifications
Aquatic Acute 1Aquatic Chronic 1Carc. 2Lact.Repr. 1A

Ergänzende Hinweise

DefinitionChEBI: A 3-oxo Delta4-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.